Correlation Between BioNTech and Eyenovia
Can any of the company-specific risk be diversified away by investing in both BioNTech and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Eyenovia, you can compare the effects of market volatilities on BioNTech and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Eyenovia.
Diversification Opportunities for BioNTech and Eyenovia
Very weak diversification
The 3 months correlation between BioNTech and Eyenovia is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of BioNTech i.e., BioNTech and Eyenovia go up and down completely randomly.
Pair Corralation between BioNTech and Eyenovia
Given the investment horizon of 90 days BioNTech SE is expected to generate 0.32 times more return on investment than Eyenovia. However, BioNTech SE is 3.09 times less risky than Eyenovia. It trades about -0.07 of its potential returns per unit of risk. Eyenovia is currently generating about -0.28 per unit of risk. If you would invest 11,258 in BioNTech SE on December 30, 2024 and sell it today you would lose (1,763) from holding BioNTech SE or give up 15.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
BioNTech SE vs. Eyenovia
Performance |
Timeline |
BioNTech SE |
Eyenovia |
BioNTech and Eyenovia Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioNTech and Eyenovia
The main advantage of trading using opposite BioNTech and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |